about
Treatment of juvenile idiopathic arthritis: a revolution in careChallenges in transitioning adolescents and young adults with rheumatologic diseases to adult Care in a Developing Country - the Brazilian experience.Burden of childhood-onset arthritis.Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis.The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies.Taxonomy for systemic lupus erythematosus with onset before adulthoodThe juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomesLow complement levels in paediatric systemic lupus erythematosus and the risk of bacteraemia.Juvenile Idiopathic Arthritis in Olmsted County, Minnesota, 1960-2013.Infection-Related Death among Persons with Refractory Juvenile Idiopathic Arthritis.Effectiveness and safety of TNF inhibitors in adults with juvenile idiopathic arthritisMyositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA).Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition.
P2860
Q26849497-7ABFE89F-9B8A-4B7A-A194-A8C2921B77DCQ33742579-C20B3A71-FDAC-4F62-89BE-6C44C2808AE1Q34036551-B17D9C3F-53AE-4C5B-91CC-23B51580B9A4Q35766646-C44F9BC1-8CF9-49F6-8207-8B5956019034Q36086954-3D992170-A811-438A-AC8A-9C1DB41E5A02Q36283423-71011412-B0CE-4B43-87B5-D9CB63AD7B5EQ36295937-E711DF0A-22BF-405A-9C23-02B11AC3C8BCQ37022721-94C0D6EC-BF2F-4E4A-B881-3352A9B011EEQ37145208-2062A2F3-EE6A-4462-B8E7-6B7106BE2ED9Q37258323-85FF4087-92B4-4351-B39D-D02EEF59EB86Q37288106-99B442FF-3BAE-4414-AD3C-D02DCC0CC537Q37356217-2D6015EC-F68C-4E54-9BF4-E279DED06A31Q37368405-2D2749E7-4448-4EF4-987D-7234FADA7F6FQ41694469-730DE90F-6ED6-4C45-99B1-B52ECE47747CQ47150341-DA624F49-E3CF-4EDB-A15D-243B4F48FF34
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mortality outcomes in pediatric rheumatology in the US.
@en
Mortality outcomes in pediatric rheumatology in the US.
@nl
type
label
Mortality outcomes in pediatric rheumatology in the US.
@en
Mortality outcomes in pediatric rheumatology in the US.
@nl
prefLabel
Mortality outcomes in pediatric rheumatology in the US.
@en
Mortality outcomes in pediatric rheumatology in the US.
@nl
P2093
P356
P1476
Mortality outcomes in pediatric rheumatology in the US.
@en
P2093
Anne S Tang
Bridget M Wright
Michael S Lauer
Philip A Roettcher
Philip J Hashkes
Sarah E Worley
Suzanne L Bowyer
P304
P356
10.1002/ART.27218
P577
2010-02-01T00:00:00Z